medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Number 6

Next >>

Ann Hepatol 2015; 14 (6)

Hepatology highlights

Teschke R

Language: English
References: 9
Page: 772-773
PDF size: 68.48 Kb.


Text Extraction

Chen S, et al. The authors from Seoul evaluated the role of serum alpha-fetoprotein (AFP) as a screening method for hepatocellular carcinoma (HCC) in Korea and and focused on patients with hepatitis B and C as the predominant risk groups. Their initial study group was large and consisted of 48,122 Koreans, with 1,873 patients who were positive for HBsAg, 393 patients who were positive for anti-HCV, and 20 individuals who were positive for both. Overall, 24 patients were diagnosed with HCC; of these, 17 were positive for HBsAg, 2 were positive for anti-HCV, and 5 showed negative results for both parameters. For all 24 patients, a quantitative serum AFP level was individually provided.


REFERENCES

  1. Bruix J, Sherman M. AASLD Practice guideline: Management of hepatocellular carcinoma: An update. Hepatology 2011; 53: 1:1020-1022. Available at: http:// www.guideline.gov/content.aspx?id=23927

  2. Lui HF. Screening for hepatocellular carcinoma. Internat J Hepatol 2011; Article ID 363151. DOI: 10.4061/2011/ 363151.

  3. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30.

  4. Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol 2014; 6: 17-32.

  5. Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J. Drug induced liver injury: accuracy of diagnosis in published reports. Ann Hepatol 2014; 13: 248-55.

  6. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-5.

  7. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. Global trends and interactions with HIV epidemic. Arch Intern Med 2003; 163: 1009-21.

  8. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrastagent- induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-4.

  9. Guevara M, Fernández-Esparrach G, Alessandria C, Torre A, Terra C, Montañà X, Piera C, et al. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology 2004; 40: 646-51.




2020     |     www.medigraphic.com